Anastomotic Outcomes in Idiopathic Pulmonary Fibrosis Patients Receiving Anti-Fibrotic Therapy: Experience of the Australian Lung Transplant Collaborative

被引：0
|
作者：
Mackintosh, J. [1 ]
Munsif, M. [2 ]
Thomson, C. [3 ]
Musk, M. [4 ]
Snell, G. [2 ]
Glanville, A. [3 ]
Chambers, D. [1 ]
Hopkins, P. [1 ]
机构：
[1] Prince Charles Hosp, Lung Transplant Unit, Brisbane, Qld, Australia
[2] The Alfred, Lung Transplant Serv, Melbourne, Vic, Australia
[3] St Vincents Hosp, Lung Transplant Unit, Sydney, NSW, Australia
[4] Royal Perth Hosp, Lung Transplant Unit, Perth, WA, Australia
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2018年 / 37卷 / 04期
关键词：
D O I：
10.1016/j.healun.2018.01.208
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
205
引用
收藏
页码：S89 / S90
页数：2
相关论文
共 50 条
  • [31] ANTI-FIBROTIC THERAPY MODULATES MORTALITY RISK ASSOCIATED WITH CIRCULATING PLASMA BIOMARKERS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Oldham, Justin
    Alqalyoobi, Shehabaldin
    Adegunsoye, Ayodeji
    Linderholm, Angela
    Hrusch, Cara
    Pugashetti, Janelle
    Boctor, Noelle
    Sperling, Anne
    Strek, Mary
    Noth, Imre
    CHEST, 2019, 156 (04) : 258A - 259A
  • [32] Anti-Fibrotic Effects of Azithromycin in Human Lung Fibroblasts from Idiopathic Pulmonary Fibrosis Patients Compared to Control Fibroblasts
    Funke, M.
    Krempaska, K.
    Schliep, R.
    Knudsen, L.
    Geiser, T. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [33] Real-life survival of idiopathic pulmonary fibrosis with anti-fibrotic medication
    Bleinc, Alexandre
    Blin, Timothee
    Legue, Sylvie
    Mankikian, Julie
    Plantier, Laurent
    Marchand-Adam, Sylvain
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 (05) : 371 - 381
  • [34] Tolerability and safety of anti-fibrotic agents for idiopathic pulmonary fibrosis in real world
    Sugimoto, Chikatoshi
    Inoue, Yoshikazu
    Arai, Toru
    Kasai, Takehiko
    Akira, Masanori
    Hayashi, Seiji
    Tachibana, Kazunobu
    Sasaki, Yumiko
    Takeuchi, Naoko
    Minomo, Syojiro
    Ikegami, Naoya
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [35] Ptpn11 Is A Novel Anti-Fibrotic Gene In Idiopathic Pulmonary Fibrosis
    Tzouvelekis, A.
    Cardenas, C. Lacks Lino
    Yu, G.
    Sakamoto, K.
    DeIuliis, J.
    Wyllie, A.
    Ahangari, F.
    Woolard, T.
    Heather, L.
    Herazo-Maya, J. D.
    Kaminski, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [36] Missing out on effective care in idiopathic pulmonary fibrosis: Racial inequality in access to anti-fibrotic therapy
    Pascoe, Amy
    Smallwood, Natasha
    RESPIROLOGY, 2023, 28 (11) : 978 - 979
  • [37] Perioperative Anti-Fibrotic Treatment Prevents Acute Exacerbation of Idiopathic Pulmonary Fibrosis After Lung Cancer Surgery
    Bongiolatti, Stefano
    Salvicchi, Alberto
    Rosi, Elisabetta
    Bargagli, Elena
    Mugnaini, Giovanni
    Gonfiotti, Alessandro
    Lavorini, Federico
    Spagnolo, Paolo
    Dell'Amore, Andrea
    Rea, Federico
    Voltolini, Luca
    LIFE-BASEL, 2024, 14 (11):
  • [38] LSC Abstract - A human lung explant model of fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
    Roach, Katy
    Newby, Chris
    Amrani, Y.
    Bradding, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [39] WEIGHT LOSS HAS A SIGNIFICANT IMPACT ON ANTI-FIBROTIC DRUG TOLERANCE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Moon, R. D. C.
    Barker, E.
    Agnew, S.
    Sutcliffe, J.
    Kwok, A.
    Spencer, L. G.
    THORAX, 2017, 72 : A250 - A250
  • [40] Anti-Fibrotic Role Of Inhaled Interferon-γ Detected By Proteomic Studies In Patients With Idiopathic Pulmonary Fibrosis
    Hasaneen, N. A.
    Haley, J.
    Foda, H. D.
    Condos, R.
    Smaldone, G. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345